The strength of synaptic inhibition depends partly on the number of GABA A receptors (GABAARs) found at synaptic sites. The trafficking of GABA ARs within the endocytic pathway is a key determinant of surface GABA AR number and is altered in neuropathologies, such as cerebral ischemia. However, the molecular mechanisms and signaling pathways that regulate this trafficking are poorly understood. Here, we report the subunit specific lysosomal targeting of synaptic GABA ARs. We demonstrate that the targeting of synaptic GABAARs into the degradation pathway is facilitated by ubiquitination of a motif within the intracellular domain of the ␥2 subunit. Blockade of lysosomal activity or disruption of the trafficking of ubiquitinated cargo to lysosomes specifically increases the efficacy of synaptic inhibition without altering excitatory currents. Moreover, mutation of the ubiquitination site within the ␥2 subunit retards the lysosomal targeting of GABA ARs and is sufficient to block the loss of synaptic GABA ARs after anoxic insult. Together, our results establish a previously unknown mechanism for influencing inhibitory transmission under normal and pathological conditions. endocytosis ͉ trafficking ͉ ischemia ͉ ion channels ͉ synapse T he strength of inhibitory synapses is a major determinant of neuronal processing and excitability and can be determined by the number of ␥-amino butyric acid type A receptors (GABA A Rs) found at synaptic sites (1-3). Moreover, in a number of neuropathologies, including status epilepticus and in vitro and in vivo models of cerebral ischemia, the rapid downmodulation of synaptic GABA A Rs has been reported to contribute to pathological disinhibition, excitotoxicity, and cell death (4-8). However, the molecular mechanisms and signaling pathways that regulate GABA A R trafficking, under normal or pathological conditions, remain unclear.
T
he strength of inhibitory synapses is a major determinant of neuronal processing and excitability and can be determined by the number of ␥-amino butyric acid type A receptors (GABA A Rs) found at synaptic sites (1) (2) (3) . Moreover, in a number of neuropathologies, including status epilepticus and in vitro and in vivo models of cerebral ischemia, the rapid downmodulation of synaptic GABA A Rs has been reported to contribute to pathological disinhibition, excitotoxicity, and cell death (4) (5) (6) (7) (8) . However, the molecular mechanisms and signaling pathways that regulate GABA A R trafficking, under normal or pathological conditions, remain unclear.
GABA A Rs undergo significant rates of endocytosis, a process that can rapidly modify receptor number at synapses (9) . Upon internalization, receptors are either reinserted into the plasma membrane or targeted for degradation (10) . The balance between these two processes is critical for determining the number of receptors expressed at synapses and hence neuronal excitability (11) . However, the regulatory mechanisms that control this endocytic sorting of synaptic GABA A Rs remain unknown.
The trafficking of membrane proteins can be regulated via the covalent attachment of the 76 amino acid (aa) peptide, ubiquitin, or ubiquitin-like proteins to lysine residues within target proteins (12, 13) . A number of studies on the role of ubiquitination in regulating synaptic function under normal conditions and in pathological conditions such as ischemia have focused on the ubiquitin-proteasome system (14) (15) (16) (17) (18) . However, within the endocytic pathway, mono-ubiquitination (or the addition of short ubiquitin chains) is a key signal that results in the specific targeting of cargo to late endosomes for subsequent lysosomal degradation (12, 19, 20) . The significance of ubiquitination in determining the endocytic fate and degradation of neurotransmitter receptors remains to be established.
In the present study we investigated the role of GABA A R ubiquitination in regulating GABA A R endosomal trafficking. We show that the GABA A R ␥2 subunit, which plays a key role in synaptic targeting, can preferentially target internalized GABA A Rs to the lysosome for degradation. We demonstrate that this process is regulated by an amino acid motif within the intracellular loop of the ␥2 subunit, which is a target for ubiquitination and that mutation of this motif retards the lysosomal targeting of GABA A Rs. Inhibition of lysosomal activity or the trafficking of ubiquitinated proteins to lysosomal compartments increases the accumulation of GABA A Rs at synapses and the efficacy of synaptic inhibition. Furthermore, we demonstrate that the loss of surface GABA A Rs observed in an in vitro model of ischemia can be inhibited by blocking ubiquitination of the lysosomal targeting motif in the ␥2 subunit. Thus, our results demonstrate that GABA A R ubiquitination is a key mechanism for regulating the strength and plasticity of synapses and the efficacy of neuronal inhibition under both normal and pathological conditions.
Results
Lysosomal Activity Regulates the Accumulation of Synaptic GABAARs and the Inhibitory Synaptic Response. We initially investigated whether the extent of lysosomal GABA A R degradation is a functionally relevant mechanism for regulating the size and number of postsynaptic GABA A Rs and hence the strength of synaptic inhibition. For this, acute coronal cortical slices from P21 rats were treated with the lysosomal protease inhibitor leupeptin (200 M, 3 h). Slices were fixed and stained with antibodies against GABA A Rs and the inhibitory presynaptic marker VIAAT (21) and imaged using confocal microscopy ( Fig. 1 A and B) . Leupeptin treatment resulted in an increase in the mean postsynaptic GABA A R cluster size (Ctrl: 0.45 Ϯ 0.04 m 2 ; Leu: 0.63 Ϯ 0.02 m 2 ) revealed by a rightward shift in the cumulative cluster area distributions ( Fig. 1 C and D) . In addition, we found a significant increase in the number of synaptic GABAergic clusters per cell (Ctrl: 15.2 Ϯ 1.2; Leu: 27.3 Ϯ 2.4) (Fig. 1E) . In contrast, clusters that were not found to have a presynaptic counterpart were unaltered in size (Ctrl: 0.40 Ϯ 0.05 m 2 ; Leu: 0.45 Ϯ 0.04 m 2 ) or number (Ctrl: 3.8 Ϯ 0.7; Leu: 3.8 Ϯ 0.9).
To assess whether this increase in the GABA A R cluster size and number resulted in modified synaptic inhibition, we compared the properties of miniature or evoked inhibitory postsynaptic currents (mIPSCs or eIPSCs) between control neurons and those treated with leupeptin using whole cell recording. In agreement with our labeling data, leupeptin treatment resulted in a significant increase in the eIPSC current amplitude (Ctrl: 223.6 Ϯ 16 pA; Leu: 412.5 Ϯ 26 pA) (Fig. 1F ). In addition, leupeptin treatment caused a sustained increase in mIPSC amplitude (41.6 Ϯ 5.1pA) compared with untreated control cells (25.3 Ϯ 2.2 pA) ( Fig. 1 G and H) revealed by the rightward shift in the cumulative amplitude relationship for mIPSCs. Leupeptin treatment also caused a significant enhancement in mIPSC frequency (Ctrl: 4.6 Ϯ 0.3 Hz; Leu: 19.6 Ϯ 1.2 Hz) ( Fig. 1 I and J) . However, leupeptin did not alter mIPSC kinetics (Table S1 ). In contrast, the mean amplitudes (Ctrl: 7.5 Ϯ 0.6 pA; Leu: 8.9 Ϯ 0.6 pA) and frequency (Ctrl: 2.5 Ϯ 0.19 Hz; Leu: 2.7 Ϯ 0.18 Hz) of miniature excitatory postsynaptic currents (mEPSC) or the eEPSC current amplitude (Ctrl: 108.8 Ϯ 7.7 pA; Leu: 118 Ϯ 8.9 pA) were unaffected by leupeptin treatment (Fig.  S1 ). Thus, blockade of lysosomal GABA A R degradation results in an increase in the number and size of synaptic GABA A R clusters leading to increased synaptic inhibition.
Identification of a Sorting Motif in the GABAAR ␥2 Subunit That
Facilitates Lysosomal Targeting of GABAARs. Having established that lysosomal degradation of GABA A Rs is an important determinant of the number of surface and synaptic GABA A Rs, we next set out to identify the molecular mechanisms that mediate lysosomal targeting of GABA A Rs. Because the ␥2 subunit is an important determinant for the trafficking of GABA A Rs, and their entry into the endocytic pathway (22) (23) (24) (25) , we examined the possible role that this subunit plays in receptor lysosomal targeting. We compared the lysosomal targeting in HEK-293 cells of GABA A Rs composed of ␣␤ and ␣␤␥2 subunits modified with N-terminal 9E10 reporters. To identify late endocytic/lysosomal compartments we coexpressed GABA A Rs with GFP-Rab7, a marker for late endosomal and lysosomal structures (26, 27) . To specifically label receptors in the endocytic pathway, live cells were labeled with myc antibody for 30 min at 4°C and then placed at 37°C to allow for internalization. After fixation and permeabilization, internalized receptors were visualized and their distribution in confocal slices showing maximum receptor internalization was compared with that for GFPRab7. Endocytosed ␣␤␥2 receptors exhibited a marked increase in targeting to late endosomes/lysosomes as demonstrated by a substantially increased colocalization with GFP-Rab7 compared with those composed of ␣␤ subunits (␣␤: 43.3 Ϯ 4.1%; ␣␤␥2: 67.8 Ϯ 5.2%) (Fig. 2 A-C ). This suggests a significant role for the ␥2 subunit in regulating the targeting of GABA A Rs to the late endosomal/lysosomal compartments.
To identify the domain of the ␥2 subunit that mediates the lysosomal targeting of GABA A Rs we exploited the ability of GABA A R ␤3 subunits to assemble into pentameric cell surface homomeric ion channels, a property that depends on residues within the N terminus of this subunit (28, 29) . As measured by antibody labeling, internalized ␤3 subunits showed a similar distribution to ␣␤ receptors with respect to GFP-Rab7 (33.8 Ϯ 3.7%) ( Fig. 2 D and H) . In contrast, a chimeric receptor (C1) in which the major intracellular domain and transmembrane domain 4 of the ␤3 subunit were exchanged for the corresponding domains of the ␥2 subunit (Fig. 2G ) exhibited enhanced targeting to lysosomes, as measured by colocalization with GFP-Rab7 similar to levels seen with ␣␤␥2 subunit containing receptors (63.3 Ϯ 3.6%) ( Fig. 2 E and  H) . Thus, the intracellular domain and/or TM4 of the ␥2 subunit are sufficient to mediate the lysosomal targeting of GABA A Rs.
To identify the region within the ␥2 subunit responsible for the late endosomal/lysosomal targeting of GABA A Rs, we constructed a set of ␤3/␥2 subunit chimeras that serially replaced sequences within C1 with those from the ␤3 subunit (Fig. 2G ). Using live cell antibody labeling experiments we followed the extent of lysosomal targeting of internalized ␤3/␥2 chimeras by their colocalization with GFP-Rab7. Compared with C1, chimeras C2, C3, C4, and C5 all showed reduced levels of colocalization with GFP-Rab7 (71.7 Ϯ 3.4% compared with 31.8 Ϯ 2.5%, 37.7 Ϯ 6.4%, 38.6 Ϯ 4.4%, 25.9 Ϯ 4.3%, respectively) ( Fig. 2 E,  F, and H, and Fig. S2 ). Thus, residues 318-337 in the ␥2-subunit intracellular domain, proximal to TM3 contain the late endosomal/lysosomal targeting sequence because replacement of this sequence with that of ␤3 abrogated the enhanced colocalization of the ␤3/␥2 chimeras with GFP-Rab7.
Blockade of Ubiquitin-Dependent Lysosomal Sorting Increases
GABAAR Functional Expression. Ubiquitination of lysine residues can act as a signal for sorting membrane proteins to the lysosome for degradation (12) . We noted that residues 318-337 of the ␥2 subunit contain a number of conserved lysine residues (Fig. S3) , suggesting that the late endosomal/lysosomal targeting of ␥2 subunit containing GABA A Rs may be dependent on ubiquitination. The ubiquitin dependent sorting of membrane proteins to the lysosome depends on a highly conserved machinery that specifically recognizes ubiquitinated membrane proteins in the early endosome and selects them for late endosomal/lysosomal sorting (30) . The hepatocyte growth factor regulated substrate (Hrs) is a key component of this initial recognition machinery and we took advantage of GFP-2FYVE, a dominant negative construct known to block the lysosomal targeting of ubiquitinated proteins by disrupting Hrs function (31) . We first assessed the ability of this construct to modulate the trafficking of GABA A Rs by assessing its effect on steady state surface levels of these receptors in transfected neurons. As measured by cell surface biotinylation, neurons transfected with GFP-2FYVE exhibited a 68.2 Ϯ 11.1% increase in the cell surface expression levels of GABA A Rs compared with those expressing GFP alone (Fig. 3 A and B) .
We further investigated whether the increase in cell surface accumulation of GABA A Rs in the presence of GFP-2FYVE alters the properties of mIPSCs using whole cell recording. Similar to our results using leupeptin, expression of GFP-2FYVE in cultured hippocampal neurons resulted in a 66.3% increase in the mean mIPSC amplitude compared with cells expressing GFP (GFP-2FYVE: 50.4 Ϯ 2.4 pA, n ϭ 9; GFP: 30.3 Ϯ 1.2 pA, n ϭ 8) (Fig.  3 C and D) . In addition, expression of GFP-2FYVE also caused a significant enhancement in mIPSC frequency compared with control cultures expressing GFP alone (GFP-2FYVE: 7.9 Ϯ 0.5 Hz, n ϭ 9; GFP: 3.2 Ϯ 0.6 Hz, n ϭ 8) (Fig. 3 C, E, and F) . As for leupeptin treatment, channel kinetics were unaffected by GFP-2FYVE expression (Table S2 ). These results demonstrate that ubiquitindependent targeting of GABA A Rs to lysosomal compartments plays a key role in regulating the number of GABA A Rs at synaptic sites together with the efficacy of neuronal inhibition.
Lysosomal Targeting of GABAARs Is Regulated by Ubiquitination of the
␥2 Subunit. Our results indicate that ubiquitination of GABA A Rs within the endocytic pathway can determine the lysosomal degradation of GABA A Rs and our mapping experiments suggested that the lysine residues within the ␥2 subunit lysosomal targeting motif are likely to be the site of ubiquitination. To analyze this further, we compared the ubiquitination of GABA A Rs containing WT ␥2 subunits or a construct in which K325, K328, K330, K332, K333, K334, and K335 within the lysosomal targeting motif were all mutated to arginine residues (␥2 K7R ). The ubiquitination of these constructs was tested in HEK cells expressing ␣1␤3 9E10 ␥2 (or ␣1␤3 9E10 ␥2 K7R ) and HA-tagged ubiquitin. Cells were lysed, and the ␥2 subunit was immunoprecipitated with anti-myc and immunoblotted with anti-HA and anti-9E10. This revealed significant levels of ubiquitination for the WT ␥2 subunit, which was largely abolished for the ␥2 K7R construct despite similar levels of ␥2 subunit immunoreactivity. Therefore, these experiments suggest that the principle sites of ubiquitination within the ␥2 subunit intracellular domain lie between residues 325 and 335 (Fig. 4D) .
We then tested the role of the respective lysine residues in facilitating sorting of ␣␤␥2 receptors to the late endosome/ lysosome. Live antibody labeling experiments showed that mutation of the lysine residues within the endocytic sorting motif did not alter receptor internalization (Fig. 4B) . In contrast, receptors expressing ␥2 K7R exhibited reduced levels of late endosomal/lysosomal targeting compared with those expressing wild-type ␥2, as assessed by colocalization with GFP-Rab7 fluorescence (␣␤␥2: 67.7 Ϯ 3.8%; ␣␤␥2 K7R : 36.3 Ϯ 3.5%) (Fig. 4 A-C) . In addition to comparing the lysosomal targeting of GABA A Rs we examined the effects of blocking lysosomal degradation on their functional expression using patch clamp recordings from transfected HEK-293 cells (17, 32) . To modulate lysosomal degradation we introduced leupeptin into expressing cells via intracellular dialysis with the patch-pipette. The magnitude of GABA activated membrane currents (I GABA ) induced by 5 ⌴ G〈〉〈 (⌭C 50 ) (17, 32) were analyzed over a time course of 30 min and normalized to that evident at time 0. In cells expressing receptors incorporating ␥2 subunits leupeptin induced a significant increase in I GABA , which at 30 min reached 207.8 Ϯ 10.6% of that seen at zero time (Fig. 4 E  and G) . In contrast in cells expressing ␥2 K7R potentiation of I GABA by leupeptin was insignificant (111.3 Ϯ 8.9%) (Fig. 4 F and G) . In agreement with our imaging studies, leupeptin did not significantly alter I GABA for cells expressing receptors composed of ␣␤ subunits (107.0 Ϯ 10.4%) (Fig. S4) . Therefore, our observations suggest that multiple lysine residues between amino acids 318-337 within the intracellular domain of the ␥2 subunit play a critical role in regulating the late endosomal/lysosomal trafficking of GABA A Rs.
Enhanced Lysosomal Targeting Underlies the Deficits of GABAAR Cell
Surface Expression After Anoxia. Protein ubiquitination is increased in the brain upon ischemic injury (33) . In addition, several studies have reported compromised synaptic inhibition and a reduction in cell surface GABA A R expression during ischemia (4, 7, 8) . Although the cellular mechanisms responsible for this pathological loss of GABA A R functional expression remain unknown, one possible explanation is altered receptor trafficking (4). Therefore, we assessed whether ubiquitin dependent trafficking of GABA A Rs plays a role in the deficit of GABA A R surface expression after ischemia. To examine this, we imaged cultured hippocampal neurons transfected with either GFP ␥2 or GFP ␥2 K7R under control conditions or during oxygen and glucose deprivation (OGD) to induce anoxia. We first investigated whether GFP ␥2 and GFP ␥2
K7R
were equally targeted to synaptic sites. We found 75.96 Ϯ 4.5% of GABA A Rs clusters expressing GFP ␥2 and 79.07 Ϯ 2.8% of GABA A Rs expressing GFP ␥2 K7R were found apposed to VIAAT labeled presynaptic inhibitory terminals (Fig. S5) . Having established that both GFP ␥2 and GFP ␥2 K7R constructs were equally targeted to synaptic sites, we imaged the fluorescence of individual GFP clusters over time in 12-16DIV cultured hippocampal cells under control and OGD conditions. Analysis of GFP ␥2 subunit containing clusters revealed a significant loss in cluster fluorescence over time under OGD conditions compared with control (OGD t ϭ 30 min: 31.1 Ϯ 2.8%; control t ϭ 30 min: 6.8 Ϯ 5.7%; P Ͻ 0.001, n ϭ 7-8) (Fig. 5 A, C, and D, and Fig. S6 ). In contrast, cells expressing GFP ␥2 K7R did not exhibit a significant loss of cluster fluorescence during OGD treatment (OGD t ϭ 30 min: 6.43 Ϯ 6.6%; control t ϭ 30 min: 13.29 Ϯ 3.0%; P Ͼ 0.05, n ϭ 7-8) (Fig.  5 B-D and Fig. S6 ). Thus, ubiquitin-dependent lysosomal targeting of GABA A Rs results in the loss of synaptic GABA A Rs during OGD treatment. In accordance with these results, the reduction in GABA A R cluster fluorescence observed during OGD was also blocked by leupeptin treatment (Fig. S7) . These results provide evidence that modified ubiquitin dependent trafficking of GABA A Rs in the endocytic pathway may underlie deficits in receptor cell surface stability after ischemia.
Discussion
The regulated endocytosis of ligand-gated ion channels is an important determinant for the efficacy of synaptic transmission (34, 35) . Within the endocytic pathway these proteins are recycled or targeted for lysosomal degradation and the impact of this endocytic sorting decision is emerging as an important determinant for neuronal excitability (11, 36) . Here, we investigated the role of regulated endocytic sorting with reference to GABA A Rs, the principal sites of fast synaptic inhibition in the brain. We demonstrate that acute inhibition of lysosomal activity increases inhibitory synaptic strength by blocking synaptic GABA A R degradation. In addition, we find that ubiquitination of a motif within the ␥2 subunit is responsible for GABA A R lysosomal targeting. Furthermore, our results suggest that enhanced ubiquitination dependent degradation of GABA A Rs may directly contribute to the previously reported reduction in the number of synaptic GABA A Rs observed in ischemia. The GABA A R ␥2 subunit confers important pharmacological, functional, and membrane trafficking properties to GABA A Rs including the selective targeting of GABA A Rs to inhibitory postsynaptic domains (22) . In this study, we compared the endocytic fate of GABA A Rs composed of ␣␤ and ␣␤␥2 subunits and found that the ␥2 subunit also plays a key role in the endocytic sorting of GABA A Rs, by facilitating the trafficking of GABA A Rs to late endocytic/lysosomal compartments. This may provide a mechanism by which neurons can specifically regulate the endocytic trafficking of synaptic (␥2 subunit containing) GABA A Rs without altering the trafficking of other GABA A Rs (lacking ␥2 subunits), which may contribute to tonic inhibition.
Using ␤3/␥2 subunit chimeras we found that a motif within the ␥2 subunit was critically important for the enhanced lysosomal targeting of GABA A Rs. This motif was found to be a direct target for ubiquitination and mutation of seven lysine residues within this motif resulted in reduced levels of GABA A R ubiquitination and compromised targeting to lysosomes. Therefore, these experiments provide compelling evidence that the lysosomal targeting of GABA A Rs depends on the ubiquitination of lysine residues between residues 317-338 of the ␥2 subunit. Ubiquitination of lysine residues within the intracellular loops of the GABA A R ␣1 and ␤3 subunits can target unassembled subunits within the endoplasmic reticulum (ER) for ER associated degradation by the proteosome, but does not appear to be involved in GABA A R endocytic trafficking (17, 18) . Moreover, this proteosomal degradation of GABA A R subunits within the secretory pathway regulates synaptic inhibition over long time scales (days) (17) . In contrast, results in this study reveal a mechanism for more rapid (tens of minutes), ␥2 subunit-specific, ubiquitination of GABA A Rs resulting in fast regulation of synaptic inhibition.
We found that blocking lysosomal degradation of GABA A Rs (with leupeptin treatment) or their ubiquitin-dependent lysosomal targeting (using the dominant negative GFP-2FYVE), caused a marked increase in both mIPSC amplitude and frequency suggesting not only an increase in the number of synaptic GABA A Rs but also an increase in the number of synaptic responses. In agreement with these findings, correlative immunofluorescence experiments revealed that blocking lysosomal GABA A R degradation resulted in an increase both in GABA A R cluster size and in the number of GABA A R clusters apposed to VIAAT positive inhibitory presynaptic terminals. The mIPSC amplitude and frequency increase is similar to that observed when surface GABA A R numbers are increased by dialysing inhibitors of GABA A R endocytosis into the postsynaptic neuron via the electrophysiological recording pipette (9) . We previously suggested that this mIPSC frequency increase reflects the increase in surface GABA A R number and mIPSC amplitude unmasking mIPSCs that were previously below the threshold for detection in the recordings rather than because of a presynaptic change (9) . The changes in GABA A R cluster number and mIPSC frequency that we report here are similarly likely to be because of the improved detection of existing established synapses (which before blockade of lysosomal targeting contained too few GABA A Rs to be detected) as a result of an increase in the availability of surface GABA A Rs rather than because of presynaptic effects such as increases in the probability of release.
Modified membrane trafficking of GABA A Rs is strongly implicated in a reduction in the number of surface and synaptic GABA A Rs, which contributes to the loss of inhibition in status epilepticus (6, (37) (38) (39) and ischemic brain injury (4, 8) , but the mechanisms have remained unclear. Here, we demonstrate that although anoxic insult reduces the number of wild type GFPtagged synaptic GABA A Rs, the synaptic expression of GABA A Rs incorporating GFP ␥2 K7R subunits (and hence no longer ubiquitinated) remained unaffected. Thus, our results suggest that ubiquitin-dependent degradation of GABA A Rs may be a key mechanism that underlies the downmodulation of synaptic inhibition after a pathological insult.
In summary, the lysosomal targeting of GABA A Rs is modulated by the ubiquitination of lysine residues between amino acids 317-328 within the intracellular domain of the ␥2 subunit. This process regulates the accumulation of GABA A Rs at inhibitory synapses and the efficacy of neuronal inhibition under basal conditions, and is responsible for deficits in neuronal inhibition after anoxia.
Materials and Methods
Antibodies and Constructs. For details see SI Materials and Methods. min for cells expressing GFP ␥2 and GFP ␥2 K7R (n ϭ 7-8, *** , P Ͻ 0.001).
